The agricultural biotechnology company, MustGrow Biologics Corp. has announced the closure of its wholly-owned Canadian marketing and distribution business, NexusBioAg, effective April 15, 2026.
NexusBioAg, which had been reselling and distributing third-party agricultural products to Canadian farmers, operated in a highly competitive, low-margin market. The decision marks a strategic shift for MustGrow, which is now focusing its attention on scaling up the production and reach of its organic mustard-derived biofertility product, TerraSante.
The closure of NexusBioAg will allow MustGrow to reallocate capital and resources to meet the growing demand for TerraSante in the U.S. market. The company stated in a press release that in 2025, demand for TerraSante from large U.S. commercial growers exceeded MustGrow’s production capacity, leading the company to prioritize inventory scalability.
To support this effort, MustGrow secured $2 million in equity financing in January 2026, along with a US$2 million credit facility from CIBC, guaranteed by Export Development Canada (EDC). These funds are being used to increase TerraSante production through international third-party manufacturers, enabling MustGrow to meet rising demand without the need for costly in-house production facilities.
Currently approved for sale in six U.S. states, including California, Florida, and Oregon, TerraSante is certified under the Organic Materials Review Institute (OMRI) and California’s Organic Input Materials (OIM) Program. MustGrow is also exploring global collaboration opportunities to expand TerraSante’s international presence.
The company states that TerraSante, a wettable powder derived from mustard plants, contains plant proteins and carbohydrates that nourish soil microbes, potentially improving soil microbiome health, nutrient availability, and water use efficiency.
